Importantly, NINJ1-targeted interventions—including monoclonal antibodies (e.g., Clone D1), blocking peptides, and small-molecule inhibitors such as glycine and muscimol—have shown efficacy in reducing inflammation and organ injury in experimental models of sepsis. This evidence concerns the gene NINJ1 and Sepsis.